Health Conditions

References

Adak B, Tekeoglu I, Ediz L. Fibromyalgia frequency in Hepatitis B carriers. Journal of Clinical Rheumatology . 6/2005;11(3): 157-159

Anon. Incidence of Acute Hepatitis B --- United States, 1990?2002. Morbidity and Mortality Weekly Review. 2004;52(51):1252-1254. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5251a3.htm. Accessed June 23, 2005, June 28,2007, and June 3, 2008.

Anon. Lamivudine for chronic hepatitis B. Drugs and Therapy Perspectives. 2000;15(4):1-5. Available at: http://www.medscape.com/viewarticle/406388 Accessed June 23, 2005, and June 3, 2008.

Baraclude: Product Package Insert. www.baraclude.com. Accessed Accessed June 23,2005, and June 3, 2008.

Canadian Association for the Study of the Liver. Therapy for chronic hepatitis B. Available at: http://www.lhsc.on.ca/casl/hbther.htm. Accessed August 2003, and June 3, 2008.

FDA Talk Paper: FDA Approves New Treatment for Chronic Hepatitis B 3/30/2005. http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01348.html: Accessed June 21,2005 , June 29,2007, and June 3, 2008.

Gish RG. Clinical trial results of new therapyies for HBV: Implications for treatment guidelines. Semin Liver Dis. 2005;25(supp 1):29-39.

Hadziyannis S, Tassopoulos N, Heathcote J, et al. Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B. New England Journal of Medicine. 6/2005: Volume 352:2673-2681 Number 26

Hepatitis B: http://www.emedicinehealth.com/articles/11343-6.asp. Accessed June 23,2005, June 29,2007, and May 29, 2008.

Hepatitis B Foundation, Hepatitis B Treatment. 2003. Available at: http://www.lhsc.on.ca/casl/hbther.htm. Accessed June 23,2005, June 29,2007, and May 29, 2008.

Hepatitis B Foundation, Hepatitis B Treatment. 2003. Available at: http://www.hepb.org/hepatitis_b_treatment.hepb Accessed June 23, 2005, June 28,2007, and May 29, 2008.

Hepatitis Foundation International. Basics: hepatitis B (HBV). 2003. Available at: http://www.hepfi.org/index.htm. Accessed June 23, 2005, June 28,2007, and May 29. 2008.

Lau GK, Tsiang M, Hou J, et al. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study. Hepatology. 2000;32(2):394-399.

Lau G, Piratvisuth T, Luo K.X., et al. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B. New England Journal of Medicine. 6/2005: Volume 352:2682-2695 Number 26

Martin P. Progress and Problems in the Management of Hepatitis B Infection. Presented at the American Association for the Study of Liver Diseases 50th Annual Meeting. Dallas, TX; 1999 November 5-9. Available at: http://www.medscape.com/viewarticle/423622 Accessed June 23,2005, and June 3, 2008.

Mercier RC, Pai M, Raebel MA, Vondracek TG. Viral hepatitis. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York: McGraw-Hill; 2005 p737-759.

Morbidity & Mortality Weekly Report, 03/11/05, vol. 54(09); 220-223, Accessed June 21,2005

National Center for Infectious Diseases. Viral hepatitis B: fact sheet. Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/b/fact.htm. Accessed June 23,2005, June 28,2007, and May 29, 2008.

Schalm SW, Heathcote J, Cianciara J, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomized trial. Gut. 2000;46(4):562-568.

Terrault NA, Wright TL. Viral hepatitis A through G. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger & Fordtran's: Gastrointestinal and Liver Disease. 6th ed. Philidelphia: W.B. Saunders Company; 1998.

Worman HJ. Hepatitis B. Columbia University. 2002. Available at: http://cpmcnet.columbia.edu/dept/gi/hepB.html. Accessed June 23, 2005, June 29,2007, and May 29, 2008.

Zhou XJ, Lim SG, Lloyd DM, Chao GC, Brown NA, Lao CL. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications. Antimicrob Agents Chemother. 2006 Mar;50(3):874-9.

Center for Disease Control. A Physician?s Guide to Chronic Hepatitis B Treatment. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/b/hbv_silent_killer.pdf. Accessed May 30, 2008.

PFDA Twinrix drug information. Available at: http://www.fda.gov/cber/label/hahbgsk032807LB.pdf. Accessed on May 30, 2008.

<< Back